4//SEC Filing
Sathyanarayanan Sriram 4
Accession 0000899243-23-002401
CIK 0001659352other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:36 PM ET
Size
9.2 KB
Accession
0000899243-23-002401
Insider Transaction Report
Form 4
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-19+2,834→ 2,834 total - Sale
Common Stock
2023-01-20$0.58/sh−1,082$622→ 1,752 total - Exercise/Conversion
Restricted Stock Units
2023-01-19−2,834→ 5,666 total→ Common Stock (2,834 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On January 19, 2022, the reporting person was granted 8,500 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Codiak BioSciences, Inc.
CIK 0001659352
Entity typeother
Related Parties
1- filerCIK 0001867898
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:36 PM ET
- Size
- 9.2 KB